'Oversaturation' of transferrin after intravenous ferric gluconate (FerrlecitR) in haemodialysis patients

Nephrology Dialysis Transplantation

Volumn 11, Issue 5, 1996, Pages 820-824

  Zanen, A L ^a,b   Adriaansen, H J ^a   Van Bommel, E F H ^a   Posthuma, R ^a   De Jong, G M Th ^a  

^a Drechtsteden Ziekenhuis   (Netherlands)

^b SINT FRANCISCUS GASTHUIS   (Netherlands)

Author keywords

Ferric gluconate; Haemodialysis; Intravenous iron; Iron toxicity

Indexed keywords

ALBUMIN; FERRIC GLUCONATE; FERRITIN; IRON; IRON LECITHIN COMPLEX; LACTATE DEHYDROGENASE; PROTEIN; TRANSFERRIN; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL PROTOCOL; FEMALE; HEMATOCRIT; HEMODIALYSIS; HUMAN; HYPOTENSION; INTRAVENOUS DRUG ADMINISTRATION; IRON BLOOD LEVEL; IRON DEFICIENCY; IRON OVERLOAD; MALAISE; MALE; PRIORITY JOURNAL;

ADULT; AGED; AGED, 80 AND OVER; FEMALE; FERRIC COMPOUNDS; HUMANS; INFUSIONS, INTRAVENOUS; IRON; MALE; MIDDLE AGED; RENAL DIALYSIS; TRANSFERRIN;

EID: 0029980758     PISSN: 09310509     EISSN: None     Source Type: Journal    
DOI: 10.1093/oxfordjournals.ndt.a027405     Document Type: Article

References (20)

1. Hamstra RD, Block MH, Schocket AL. Intravenous iron dextran in clinical medicine. JAMA 1980; 243: 1726-1731
2. Van Wyck DB. Iron dextran in chronic renal failure. Semin Dial 1991; 4: 112-114
3. Nyvad O, Danielsen H, Madsen O. Intravenous iron-sucrose complex to reduce epoietin demand in dialysis patients. Lancet 1994; 344: 1305-1306
4. Fishbane S, Frei GL, Maesaka J. Reduction in recombinant human erythropoietm doses by the use of chronic intravenous iron supplementatrion. Am J Kidney Dis 1995; 26: 41-46
5. Geisser P, Baer M, Schaub E. Structure and histology of parenteral iron preparations. Drug Res 1992; 42: 1439-1452
6. Henderson PA, Hillman RS. Characteristics of iron dextran utilization in man. Blood 1969, 34: 357-375
7. Auerbach M, Witt D, Toler W, Fierstein M, Lerner RG, Ballard H. Clinical use of the total dose intravenous infusion of iron dextran. J Lab Clin Med 1988; 111: 566-570
8. Jacobs. Death due to iron parenterally. South Med J 1969; 62: 216-217
9. Van Wyck DB et al. Iron status in patients receiving EPO for dialysis-associated anemia. Kidney Int 1989; 35: 712-716
10. Pascual J, Teruel JL, Liano F, Sureda A, Ortuno J. Sodium ferric gluconate complex given intravenously for iron deficiency in hemodialysis. Clin Nephrol 1991; 35: 87
11. Pascual J, Teruel JL, Liano F, Sureda A, Ortuno J. Intravenous Fe-gluconate-Na for iron deficient patients on hemodialysis. Nephron 1992; 60: 121
12. Allegra V, Mengozzi G, Vasile A. Iron deficiency in maintenance hemodialysis patients assessment of diagnosis criteria and of three different iron treatments. Nephron 1991; 57: 175-182
13. Baker E, Morgan H, Iron transport. In: Brock JH, Halliday JW, Pippard MJ, Powell LW. Iron Metabolism in Health and Disease Saunders, 1994; 63-86
14. Aruoma OI. Kaur H, Halliwell B. Oxygen free radicals and human diseases. J R Soc Health 1991; 111: 172-177
15. Ward PA, Warren JS, Till GO, Varani J, Johnson KJ. Modification of disease by preventing free radical formation: a new concept in pharmacological intervention. Baillière's Clin Haematol 1989; 2: 391-402
16. Rosenmund A, Brand B, Straub PW. Hyperlactataemia, hyperkalaemia and heart block in acute iron overload; the fatal role of the hepatic iron-incorporation rate in rats on ferric citrate infusions. Eur J Clin Invest 1988; 18: 69-74
17. Gokal R, Millard PR, Weatherall DJ, Callender STE, Ledingham JGC, Oliver DO. Iron metabolism in haemodialysis patients: a study of the management of iron therapy and overload. Q J Med 1979; 48: 369-391
18. Rolla G, Bucca C, Brussino L Systemic reactions to intravenous iron therapy in patients receiving angiotensin converting enzyme inhibitor. J Allergy Clin Immunol 1994; 93: 1074-1075
19. Gutteridge JMC, Halliwell B, Iron toxicity and oxygen free radicals. Baillière's Clin Haematol 1989; 2: 195-256
20. Gutteridge JMC, Identification of malondialdehyde as the TBA-reactant formed by bleomycin-iron free radical damage to DNA. FEBS Lett 1979; 105: 278-282